Produktdetaljer
Om bidragsyterne
Dr. Jordi Rello, MD. Chief, Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Institut Pere Virgili, Tarragona, SPAIN."<i>Nosocomial Pneumonia</i> achieves its stated goal of seeking to present current knowledge on the pathophysiology, clinical presentation, diagnosis, and treatment of nosocomial pneumonia. Clinicians interested in this topic will find the text a useful and worthwhile compilation." (Journal of the <i>American Medical Association</i>, December 3, 2008) <p>“The main purpose of this book is to give physicians who care for patients at risk for nosocomial pneumonia a concise and up-to-date reference and management guide, and I would say the book succeeds in that task. It is a concise, well-referenced overview…. This is a useful text that compiles a substantial body of information … in a convenient source. The major strengths of the book are the authoritative international list of contributors and the clear focus.” (<i>Respiratory Care</i>, November 2008)</p> <p>"The book is well-organized, well-written, easy to read and understand and timely in its subject matter." (<i>ADVANCE for Respiratory Care Practitioners</i>)</p> <p>"This is a good overview of an important subject." (<i>Doody's Book Reviews</i>)</p>
Nosocomial Pneumonia: Strategies for Management is dedicated specifically to this most common hospital acquired respiratory infection and reviews important new advances in therapeutics, including drug resistance. It is an essential resource for all postgraduates and specialist physicians in pulmonology and infectious diseases.
List of Contributors.
Abbreviations.
1. Health Care Associated-Pneumonia: Epidemiology, Microbiology and Clinical Outcomes (Dr. Marcos I. Restrepo and Dr. Antonio Anzuelo, San Antonio, Texas. US).
2. Prevention of Hospital-Acquired Pneumonia (Dr. Rafael Sierra and Antonio Gordillo, Cádiz, Spain).
3. Role of the microbiology laboratory in the diagnosis of ventilator-associated pneumonia (Dr. Emilio Bouza, Dra. Almudena Burillo, Dra. Patricia Muñoz, Madrid, Spain).
4. Pathophysiology of Pneumonia (Dra Amalia Alcón, Dr. Mauricio Valencia, Dr. Antoni Torres, Barcelona, Spain).
5. Clinical approach to the patient with HAP (Dr. Jordi Rello, Tarragona, Spain & Dr. Miguel Gallego, Sabadell, Spain).
6. Pneumonia due to Pseudomonas aeruginosa (Dr. Jordi Vallés and Dra. Dolors Marisca, Sabadell. Spain).
7. Hospital acquired-pneumonia caused by Staphylococcus aureus (Dra. Despoina Koulenti, Athens, Greece; Dr. Kemal Agbaht, Ankara, Turkey).
8. Nosocomial pneumonia by Acinetobacter baumannii (Dr. José Garnacho-Montero and Da. Eugenia Pachón, Dr. J.M. Cisneros, Sevilla, Spain).
9. Fungal pneumonia (Dr. George Dimopoulos, Dr. E. Papadomichelakis, Dr. P. Kopteridis, Athens, Greece).
10. General pharmacologic considerations and dose adjustment in antibiotic therapy for HAP (Dr. Pierluigi Viale and Dr. Federico Pea, Udine, Italy).
11. Minimally Invasive Diagnostic Strategy in Immunocompromized Patients with Pulmonary Infiltrates (Dra. Sandra. De Miranda and Dra. Élie Azoulay, Paris, France).
12. Pneumonia in trauma patients (Dra. Helene A. Haeberle and Dr. Wolfgang A. Krueger, Tubingen. Germany).
13. Acute Respiratory Distress Syndrome and pneumonia (Dr. Jean Chastre, Dr. Charles-Edouard Luyt, Dr. Jean Louis Trouillet, Dr. Alain Combes, Paris, France).
14. Assessment of patients with poor resolution of Hospital Acquired Pneumonia (Dr. Richard G. Wunderink, Dr. Keenan A. Hawkins, Chicago, USA).
15. Approach to Patients with recurrent VAP (Dr. Grant W. Waterer, Perth, Australia; Dr. Diego López. Madrid. Spain).
16. Costs for Hospital-Acquired Pneumonia & Ventilator-Associated Pneumonia (Dr. Andrew F. Shorr and Dr. William L. Jackson, Washington, USA).
Index.
In this new work, leading international authorities present an update on current best practice for the diagnosis, treatment, and prevention of nosocomial pneumonia. The first section of the book describes the environmental factors that lead to infection, and the clinical approaches appropriate to patients at risk. There then follows a series of chapters dedicated to each of the principal pathogens such as Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter baumannii and the specific strategies by which infections with these organisms may be combated. Finally, the authors address the problems associated with particular risk groups, including the immuno-compromised, trauma patients, and the presence of concomitant morbidities such as Acute Respiratory Distress Syndrome.
This volume will be welcomed by pulmonologists, intensivists, and by all clinicians involved in managing pulmonary infections acquired in the hospital sett